Molecular Response Announces Key Agreement in Translational Oncology with OncoMed Pharmaceuticals

News   Feb 27, 2012

 
Molecular Response Announces Key Agreement in Translational Oncology with OncoMed Pharmaceuticals
 
 
 

RELATED ARTICLES

First Successful Gene Therapy Trial Reported for People with Hemophilia A

News

Patients with hemophilia A who received a single infusion of an investigational gene therapy showed improved levels of the essential blood clotting protein FVIII, with 11 of 13 achieving normal or near-normal FVIII levels.

READ MORE

Blood Sample Detection Method for Multiple Sclerosis Discovered

News

A method for quickly detecting signs of multiple sclerosis has been developed by a University of Huddersfield research team. The process will avoid the invasive, painful process of collecting fluid from the brain and spine

READ MORE

Should Historic Doping Issues Strip All Athletes of World Records?

News

A proposal had been put forward by the European Athletics Council to disregard all world records set before 2005 due to issues with doping. However, a recent publication suggests these plans should be abolished.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE